Important location change: The Finch, Willem Einthovenstraat 13, 2342 BH Oegstgeest.
Join us for an inspiring TechTalk where innovators, researchers, and industry professionals come together to explore the latest developments in life sciences and technology.
The event will focus on current developments in the field, with speakers sharing their work, ideas, and experiences. It’s a chance to hear what others are working on, ask questions, and get a feel for the projects shaping the park right now.
Speakers:
During the afternoon, five speakers will share short insights with you into their work:
Dr. Ingrid de Visser-Kamerling from INFECTA
INFECTA is a clinical research organization based at the Leiden Bio Science Park, accelerating infectious disease product development through Controlled Human Infection Models and first-in-human studies.
Dr. Koen van der Maaden from Leiden University Medical Center
Focuses on the development of therapeutic cancer vaccines that aim to induce new cancer-specific T-cell responses, with dendritic cells playing a central role in initiating effective immunity.
Matthias Barz from Leiden University
Leads efforts in advancing biotherapeutic delivery solutions and focuses on creating innovative therapeutic materials using polypept(o)ides to address complex medical challenges.
Simone Joosten from Leiden University Medical Center
The Leiden Vaccine Group unites partners in the field of vaccine development in the Leiden area to accelerate vaccine development. Recognizing the importance of integrating and aligning knowledge and goals to create highly effective vaccines for future generations is central to the Leiden Vaccine Group’s mission.
Anna Beukenhorst from Leyden Labs
Leyden Labs develops intranasal antibody technology targeting viruses like influenza and coronaviruses at the point of entry, offering a practical, non-vaccine approach to stopping infections early.
Registration is now full.
